Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
JCO Precision Oncology
|
March 18, 2026
Genomic Features and Response to Poly(ADP-ribose) Polymerase Inhibition in Metastatic Castration-Resistant Prostate Cancer
Jeffery C W Chang, Subhiksha Nandakumar, Konrad H Stopsack, et al.
Gynecologic Oncology
|
March 16, 2024
Mainstreaming in parallel with ovarian cancer tumor testing to improve genetic testing uptake
Maureen Byrne, Tiffany Y Sia, Christopher Fong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 29, 2025
Clinical Implications of The Cancer Genome Atlas Molecular Classification System in Esophagogastric Cancer
Henry S Walch, Raktim Borpatragohain, Justin Jee, et al.
Nature Medicine
|
August 15, 2024
DNA liquid biopsy-based prediction of cancer-associated venous thromboembolism
Justin Jee, A Rose Brannon, Rohan Singh, et al.
Gynecologic Oncology
|
August 14, 2025
Germline landscape of high grade serous ovarian cancer across age groups: Is age just a number?
Tiffany Y Sia, Sara Moufarrij, Juliet Milani, et al.
Cancer Cell
|
October 27, 2023
Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers
Evelyn Jiagge, Dexter X Jin, Justin Y Newberg, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 3, 2026
Integrated Clinicogenomic Risk Modeling for Metachronous Second Primary Cancers
Johnathan Amsalem, Irina Ostrovnaya, Andrew R Marderstein, et al.
Nature Medicine
|
January 3, 2025
Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival
Anna M Varghese, Maria A Perry, Joanne F Chou, et al.
Nature Communications
|
January 13, 2021
Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesis
Teng Gao, Ryan Ptashkin, Kelly L Bolton, et al.
Cancer Cell
|
September 30, 2022
Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors
Amin H Nassar, Elio Adib, Sarah Abou Alaiwi, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
JCO Precision Oncology
|
March 18, 2026
Genomic Features and Response to Poly(ADP-ribose) Polymerase Inhibition in Metastatic Castration-Resistant Prostate Cancer
Jeffery C W Chang, Subhiksha Nandakumar, Konrad H Stopsack, et al.
Gynecologic Oncology
|
March 16, 2024
Mainstreaming in parallel with ovarian cancer tumor testing to improve genetic testing uptake
Maureen Byrne, Tiffany Y Sia, Christopher Fong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 29, 2025
Clinical Implications of The Cancer Genome Atlas Molecular Classification System in Esophagogastric Cancer
Henry S Walch, Raktim Borpatragohain, Justin Jee, et al.
Nature Medicine
|
August 15, 2024
DNA liquid biopsy-based prediction of cancer-associated venous thromboembolism
Justin Jee, A Rose Brannon, Rohan Singh, et al.
Gynecologic Oncology
|
August 14, 2025
Germline landscape of high grade serous ovarian cancer across age groups: Is age just a number?
Tiffany Y Sia, Sara Moufarrij, Juliet Milani, et al.
Cancer Cell
|
October 27, 2023
Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers
Evelyn Jiagge, Dexter X Jin, Justin Y Newberg, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 3, 2026
Integrated Clinicogenomic Risk Modeling for Metachronous Second Primary Cancers
Johnathan Amsalem, Irina Ostrovnaya, Andrew R Marderstein, et al.
Nature Medicine
|
January 3, 2025
Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival
Anna M Varghese, Maria A Perry, Joanne F Chou, et al.
Nature Communications
|
January 13, 2021
Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesis
Teng Gao, Ryan Ptashkin, Kelly L Bolton, et al.
Cancer Cell
|
September 30, 2022
Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors
Amin H Nassar, Elio Adib, Sarah Abou Alaiwi, et al.
Page
of 3